All In Biotech

Drug Trial Radar · NCT07174414

Cilostazol for Prevention of Recurrent Stroke Trial

Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 2,000 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

2,000

Planned (sponsor's estimate)

Start

Oct 15, 2026

Primary completion

Jul 2031

Study completion Jul 2031

Sponsor

Lead sponsor
Stanford UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS); Yale University; University of Cincinnati; Medical University of South Carolina
First posted
Sep 16, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical study is to learn if adding a medicine called cilostazol to usual treatment can help prevent another stroke, a heart attack, or death in patients who had a stroke caused by a blocked blood vessel, or a "mini-stroke" (also called a TIA), in the past 6 months. To determine if cilostazol is safe and effective at lowering the chance of strokes, heart attacks and deaths, the study will compare cilostazol to a placebo, a pill that looks the same as cilostazol but has no medicine in it. Participants will: * Be assigned by chance to take either cilostazol or a placebo, along with their usual medicine. * Not know which one they are taking, and neither will the study team, which keeps the results fair. * Be followed for up to 5 years to see if they have a stroke, heart attack, or major bleeding. See the Clarity study website for more information: https://www.claritystrokestudy.org/

Conditions

  • Stroke Recurrence
  • Myocardial Infarction
  • Vascular Death
  • Ischemic Stroke
  • TIA (Transient Ischemic Attack)
  • Stroke (CVA) or Transient Ischemic Attack
  • Recurrent Stroke

Interventions

  • Cilostazol 100 mg TabletsDrug

    The standard dosing regimen is an initial 2-week period during which participants take one tablet of cilostazol (100 mg) orally once daily followed by a maintenance phase in which they take one tablet twice daily. For participants who are on certain interacting drugs or who experience adverse reactions on the standard dosing regimen, the dose is reduced to half a tablet twice daily.

  • PlaceboDrug

    The standard dosing regimen is an initial 2-week period during which participants take one placebo tablet, which matches cilostazol 100 mg tablets, orally once daily followed by a maintenance phase in which they take one tablet twice daily. For participants who are on certain interacting drugs or who experience adverse reactions on the standard dosing regimen, the dose is reduced to half a tablet twice daily.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to first occurrence of any component of the composite of ischemic stroke, acute myocardial infarction, or ischemic vascular death (MACE).Time frame: Up to 5 years after randomization

Locations

54 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama Hospital - Birmingham

    Birmingham, Alabama · Recruiting

  • Chandler Regional Medical Center

    Chandler, Arizona · Recruiting

  • Kaiser Permanente Fontana Medical Center

    Fontana, California · Recruiting

  • UCSD Health La Jolla

    La Jolla, California · Recruiting

  • Kaiser Permanente Los Angeles Medical Center

    Los Angeles, California · Recruiting

  • Cedars-Sinai Medical Center

    Los Angeles, California · Recruiting

  • Casa Colina Hospital

    Pomona, California · Recruiting

  • Kaiser Permanente San Diego Medical Center

    San Diego, California · Recruiting

  • Stanford University

    Stanford, California · Recruiting

  • Intermountain Health - St. Mary's Medical Center

    Grand Junction, Colorado · Recruiting

  • Yale New Haven Hospital

    New Haven, Connecticut · Recruiting

  • UF Health Jacksonville

    Jacksonville, Florida · Recruiting

  • Emory University Hospital

    Atlanta, Georgia · Recruiting

  • Grady Memorial Hospital

    Atlanta, Georgia · Recruiting

  • Memorial Hospital of Carbondale

    Carbondale, Illinois · Not yet recruiting

  • University of Iowa Medical Center

    Iowa City, Iowa · Recruiting

  • University of Kansas Hospital

    Kansas City, Kansas · Recruiting

  • University of Maryland Medical Center

    Baltimore, Maryland · Not yet recruiting

  • Boston Medical Center

    Boston, Massachusetts · Recruiting

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts · Recruiting

  • University of Michigan - University Hospital

    Ann Arbor, Michigan · Recruiting

  • Mclaren Flint

    Flint, Michigan · Recruiting

  • Abbott Northwestern Hospital

    Minneapolis, Minnesota · Recruiting

  • M Health Fairview University of Minnesota Medical Center

    Minneapolis, Minnesota · Recruiting

  • Regions Hospital

    Saint Paul, Minnesota · Recruiting

  • Barnes-Jewish Hospital

    St Louis, Missouri · Recruiting

  • SSM Health St. Louis University Hospital

    St Louis, Missouri · Recruiting

  • Kings County Hospital Center

    Brooklyn, New York · Recruiting

  • NYU Langone Hospital - Brooklyn

    Brooklyn, New York · Recruiting

  • NYP Weill Cornell Medical Center

    New York, New York · Not yet recruiting

  • Duke University Hospital

    Durham, North Carolina · Not yet recruiting

  • New Hanover Regional Medical Center

    Wilmington, North Carolina · Recruiting

  • Wake Forest Baptist Medical Center

    Winston-Salem, North Carolina · Recruiting

  • Cleveland Clinic Akron General

    Akron, Ohio · Not yet recruiting

  • University of Cincinnati

    Cincinnati, Ohio · Recruiting

  • OSU Wexner Medical Center

    Columbus, Ohio · Recruiting

  • Oklahoma University Medical Center

    Oklahoma City, Oklahoma · Recruiting

  • Providence St. Vincent Medical Center

    Portland, Oregon · Not yet recruiting

  • Oregon Health & Science University Hospital

    Portland, Oregon · Recruiting

  • UPMC Hamot

    Erie, Pennsylvania · Not yet recruiting

Showing 40 of 54 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.